Isabel Batteria

Results from a small study show that vemurafenib is an effective and well-tolerated treatment option for patients with BRAF V600E-positive papillary thyroid cancer.

Case study shows ultrasound-guided percutaneous ethanol ablation is a well-tolerated and effective option for patients with thyroid cancer who elect not to undergo thyroidectomy.

Radiofrequency ablation and percutaneous laser ablation are both effective and safe for the management of benign thyroid nodules, with no significant differences in nodule volume reduction between the two techniques.

Researchers report that overweight and obese patients undergoing minimally invasive video-assisted thyroidectomy (MIVAT) are not at increased risk for surgical complications.

Clinician-performed ultrasound can identify non-palpable pathologic lateral lymph nodes in a significant percentage of patients with differentiated thyroid cancer who previously underwent radiologist-performed ultrasound, potentially leading to better surgical outcomes.

Study results show patients with the disorder report a sever burden of illness, with high rates of hospital and emergency room visits and significant negative impact on activities of daily living.

Study finds that language is not a major barrier to access to thyroid cancer care for Hispanic patients at a large urban hospital with ample interpretation services and a robust community network.

Swedish women who followed a modified Paleolithic diet for two years experienced a nearly 50% decrease in iodine levels, accompanied by an increase in thyroid-stimulating hormone and a decrease in FT3 levels.

Analysis of cancer surveillance, insurance coverage, and household income data indicates that thyroid cancer rates are positively correlated with higher rates of insurance coverage and higher income.

For properly selected patients with small PTC nodules active surveillance is a viable management option associated with a very low rate of short-term progression